Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NGL FINE CHM   MYLAN
EQUITY SHARE DATA
    NGL FINE CHM
Mar-23
MYLAN
Dec-18
NGL FINE CHM/
MYLAN
5-Yr Chart
Click to enlarge
High Rs2,5693,978-   
Low Rs1,1612,190-   
Sales per share (Unadj.) Rs450.01,830.6-  
Earnings per share (Unadj.) Rs33.249.7-  
Cash flow per share (Unadj.) Rs51.4392.5-  
Dividends per share (Unadj.) Rs1.750-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs360.11,980.4-  
Shares outstanding (eoy) m6.18514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.11.7 246.0%   
Avg P/E ratio x56.262.0 90.6%  
P/CF ratio (eoy) x36.37.9 461.3%  
Price / Book Value ratio x5.21.6 332.5%  
Dividend payout %5.30-   
Avg Mkt Cap Rs m11,5231,586,770 0.7%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m3690-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m2,781941,863 0.3%  
Other income Rs m550-   
Total revenues Rs m2,836941,863 0.3%   
Gross profit Rs m350243,719 0.1%  
Depreciation Rs m113176,354 0.1%   
Interest Rs m1845,300 0.0%   
Profit before tax Rs m27422,065 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m69-3,510 -2.0%   
Profit after tax Rs m20525,575 0.8%  
Gross profit margin %12.625.9 48.6%  
Effective tax rate %25.1-15.9 -157.7%   
Net profit margin %7.42.7 271.4%  
BALANCE SHEET DATA
Current assets Rs m1,627525,936 0.3%   
Current liabilities Rs m583383,465 0.2%   
Net working cap to sales %37.515.1 248.1%  
Current ratio x2.81.4 203.4%  
Inventory Days Days6584 78.0%  
Debtors Days Days86593 926.5%  
Net fixed assets Rs m1,244182,706 0.7%   
Share capital Rs m31501 6.2%   
"Free" reserves Rs m2,1950-   
Net worth Rs m2,2251,018,924 0.2%   
Long term debt Rs m211,099,746 0.0%   
Total assets Rs m2,8712,733,150 0.1%  
Interest coverage x15.91.5 1,070.5%   
Debt to equity ratio x01.1 0.9%  
Sales to assets ratio x1.00.3 281.1%   
Return on assets %7.82.6 300.0%  
Return on equity %9.22.5 366.9%  
Return on capital %13.03.2 408.8%  
Exports to sales %74.30-   
Imports to sales %9.90-   
Net fx Rs m1,7900-   
CASH FLOW
From Operations Rs m353195,719 0.2%  
From Investments Rs m-270-101,165 0.3%  
From Financial Activity Rs m-11-91,177 0.0%  
Net Cashflow Rs m721,621 4.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare NGL FINE CHM With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare NGL FINE CHM With: TTK HEALTHCARE  DR. REDDYS LAB  LINCOLN PHAR  ZENOTECH LABS  ZOTA HEALTH CARE  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.